Swanson Christopher R B, Ford Grayson J, Mattey Ashley P, Gourbeyre Léa, Flitsch Sabine L
Manchester Institute of Biotechnology, School of Chemistry, The University of Manchester, 131 Princess Street, M1 7DNManchester, United Kingdom.
ACS Cent Sci. 2023 Jan 11;9(1):103-108. doi: 10.1021/acscentsci.2c01169. eCollection 2023 Jan 25.
Iminosugar scaffolds are highly sought-after pharmaceutical targets, but their chemical synthesis is lengthy and can suffer from poor scalability and purification. Here we report protecting-group-free chemoenzymatic and biocatalytic cascades to synthesize iminosugars from sugar-derived aminopolyols in two steps. Using galactose oxidase variant F followed by a chemical or enzymatic reduction provided an efficient one-pot route to these targets, with product formation >70%. Key to success of this strategy was the application of genome mining, which identified bacterial shikimate dehydrogenases as promiscuous iminosugar reductases. The cell-free protocols allowed for isolation of highly polar iminosugar products from biotransformations in a single step through development of a gradient-elution cation exchange purification. The two-step pathway provides a short synthetic route that can be used as a cell-free platform for broader iminosugar synthesis.
亚氨基糖支架是备受追捧的药物靶点,但其化学合成过程冗长,且存在可扩展性差和纯化困难的问题。在此,我们报道了无保护基的化学酶促和生物催化级联反应,可分两步从糖衍生的氨基多元醇合成亚氨基糖。使用半乳糖氧化酶变体F,随后进行化学或酶促还原,为这些靶点提供了一条高效的一锅法路线,产物形成率>70%。该策略成功的关键在于基因组挖掘的应用,它确定了细菌莽草酸脱氢酶为混杂的亚氨基糖还原酶。通过开发梯度洗脱阳离子交换纯化方法,无细胞方案允许在一步中从生物转化中分离出高极性的亚氨基糖产物。两步法途径提供了一条短的合成路线,可作为更广泛的亚氨基糖合成的无细胞平台。